Treatment Registry
TR-0264 ActiveRecorded September 2, 2026

Compounded semaglutide

Sold by WePeptideRx · every compounded semaglutide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$149

Medication · Sitewide banner 'from' price (contradicts the pricing-page product card)$149

Added from the figures recorded below.

Price

TermPer monthCharged today
Sitewide banner 'from' price (contradicts the pricing-page product card)

Semaglutide from $149, Tirzepatide from $159

source

Per month$149Charged today$149
Visit WePeptideRx

We earn nothing from this link. WePeptideRx has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

StatesAll states except Alabama and Mississippi
PrescriberLive visit
Cancellation“You may cancel or pause your subscription at any time. Cancellation must be requested before your next billing cycle to avoid charges for the upcoming period.”

Not yet checked: pharmacy, membership and consult fee.

Recorded from wepeptiderx.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026The site's persistent top banner (present on nearly every page) advertises 'Semaglutide from $149, Tirzepatide from $159', but the actual Pricing page product cards show Compounded Semaglutide + B12 starting at $189 (Dose 1, 30-day) and Compounded Tirzepatide + B12 starting at $199 (Dose 1, 30-day) — the banner figures are $40 below the cheapest listed dose tier for both drugs. Both compounded GLP-1 products are sold bundled with B12 (and Glycine on monthly, not 90-day, plans), not as single-ingredient semaglutide/tirzepatide, per the product descriptions. Two states are explicitly excluded: 'Not Yet Available (2): Alabama, Mississippi.' The site's built HTML also contains stray developer/QA comments (about canonical tags and robots meta) that render as visible page text through this tool because they are not wrapped in recognized comment or script tags — these were identified as non-content and excluded from all quotes above.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0264
Readings
1

Related records

What else WePeptideRx sells

All WePeptideRx programs and terms

Compounded semaglutide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 298 records of the same molecule.

Cite this entry

Treatment Registry. (2026). WePeptideRx compounded semaglutide (TR-0264). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0264

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.